Astera Labs, Inc. $ALAB Stock Position Lifted by Y Intercept Hong Kong Ltd

Y Intercept Hong Kong Ltd grew its position in Astera Labs, Inc. (NASDAQ:ALAB) by 497.2% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 31,743 shares of the company’s stock after acquiring an additional 26,428 shares during the quarter. Y Intercept Hong Kong Ltd’s holdings in Astera Labs were worth $3,479,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in ALAB. Reflection Asset Management acquired a new position in Astera Labs in the fourth quarter worth $25,000. Smartleaf Asset Management LLC lifted its position in shares of Astera Labs by 422.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock worth $32,000 after buying an additional 152 shares during the last quarter. Hilltop National Bank boosted its holdings in shares of Astera Labs by 100.0% in the 4th quarter. Hilltop National Bank now owns 200 shares of the company’s stock valued at $33,000 after buying an additional 100 shares during the period. Aventura Private Wealth LLC bought a new stake in shares of Astera Labs during the 4th quarter valued at about $33,000. Finally, Towarzystwo Funduszy Inwestycyjnych PZU SA bought a new stake in shares of Astera Labs during the 4th quarter valued at about $33,000. 60.47% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Astera Labs

In related news, COO Sanjay Gajendra sold 400,000 shares of the stock in a transaction dated Thursday, May 21st. The shares were sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the completion of the sale, the chief operating officer owned 5,064,213 shares in the company, valued at $1,470,141,033.90. This trade represents a 7.32% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 136,974 shares of the business’s stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $442.01, for a total transaction of $60,543,877.74. Following the completion of the transaction, the director owned 1,287,524 shares in the company, valued at approximately $569,098,483.24. This trade represents a 9.62% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 2,164,441 shares of company stock valued at $526,198,280. 10.40% of the stock is currently owned by company insiders.

Analyst Ratings Changes

ALAB has been the topic of a number of recent research reports. Barclays raised their target price on shares of Astera Labs from $165.00 to $200.00 and gave the stock an “equal weight” rating in a report on Thursday, May 7th. Morgan Stanley increased their price target on Astera Labs from $210.00 to $240.00 and gave the stock an “overweight” rating in a research report on Wednesday, May 6th. UBS Group boosted their price objective on Astera Labs from $205.00 to $400.00 and gave the company a “neutral” rating in a research report on Monday, June 29th. Bank of America upped their price objective on Astera Labs from $240.00 to $450.00 and gave the stock a “neutral” rating in a research note on Tuesday, June 23rd. Finally, JPMorgan Chase & Co. raised their target price on Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a research note on Wednesday, May 6th. Twelve research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Astera Labs has an average rating of “Moderate Buy” and an average target price of $265.75.

Astera Labs Price Performance

Shares of NASDAQ ALAB traded down $52.62 during trading hours on Tuesday, hitting $380.12. 2,859,701 shares of the company’s stock were exchanged, compared to its average volume of 5,683,588. The stock has a market capitalization of $65.16 billion, a price-to-earnings ratio of 256.58, a PEG ratio of 4.66 and a beta of 3.66. The company’s 50-day moving average price is $314.72 and its 200-day moving average price is $205.99. Astera Labs, Inc. has a 1-year low of $88.18 and a 1-year high of $499.48.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, beating the consensus estimate of $0.54 by $0.07. Astera Labs had a net margin of 26.72% and a return on equity of 18.49%. The business had revenue of $308.36 million for the quarter, compared to analyst estimates of $292.19 million. During the same period in the previous year, the business earned $0.33 EPS. The firm’s revenue was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, research analysts expect that Astera Labs, Inc. will post 1.84 earnings per share for the current year.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.